Breast cancer is a complex heterogeneous disease which has traditionally been subclassified depending, amongst other factors, on the expression of different receptor proteins, such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [1]. This evidence concerns the gene ERBB2 and breast cancer.